HIPINE (02583)
- 117.000
- -1.400-1.18%
HIPINE (02583) News
Cipani (02583.HK) has been added to the list of securities eligible for trading under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs.
Gelonghui, March 8th ┃ Xipuni (02583.HK) announced that according to (i) the "Notice on the Adjustment of Target Securities under Shanghai-Hong Kong Stock Connect" issued by the Shanghai Stock Exchange and (ii) the "Announcement on the Adjustment of Target Securities List under Shenzhen-Hong Kong Stock Connect" issued by the Shenzhen Stock Exchange, the company's H shares ("H shares") have been included in the target securities list for Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect (collectively referred to as "Stock Connect"), effective from March 9, 2026. The board of directors believes that the inclusion of the company’s H shares in the Stock Connect target securities list will help further expand the company’s investor base and enhance the trading liquidity of the company’s H shares.
Express News | The list of eligible securities for Stock Connect's Hong Kong stock trading link has been adjusted to include Lead Intelligent Equipment, Deepexi Technology, JD.com Industrial, and others, effective from March 9.
A Preview of the March Adjustment for Stock Connect: 44 Hong Kong Stocks Expected to Be Included, with Insilico Medicine and JD.com Industrial Among Them
A total of 44 securities are most likely to be newly added to the Hong Kong Stock Connect, with the adjustment set to take effect officially starting from next Monday, March 9.
HIPINE: NOTICE OF BOARD MEETING
The adjustment to the MSCI China Index takes effect after today's trading session! Four Hong Kong-listed stocks have been newly included: Changfei Fiber Optic Cable, Pony AI, SenseTime, and Hesai. See the complete list in the infographic below.
The results of the February 2026 quarterly adjustment for the MSCI China Index will take effect after the market close on February 27, 2026. As a key benchmark tracked by global passive funds, newly included stocks are expected to see inflows of passive capital around the effective date of February 27.
Cipani (02583) has been included in the Hang Seng Composite Index and is expected to become a target for Shanghai-Hong Kong Stock Connect.
On February 13, Hang Seng Indexes Company announced the results of the quarterly review of the Hang Seng Index series up to December 31, 2025, in which Xipuni (02583) was included in the Hang Seng Composite Index.
The adjustment to the short-selling pool takes effect today, with 51 companies, including JF Pharmaceutical (02595), entering the new short-selling list.
The Hong Kong Stock Exchange revised the list of designated securities eligible for short selling on February 10, with the specific adjustments taking effect today.
HK Stock Concept Tracker | Greenland Crisis Boosts Safe-Haven Demand, Precious Metal Prices Hit New Highs (with Related Stocks)
Gold prices hit a record high as the Greenland crisis boosts safe-haven demand.
A shareholder of Xipuni (02583) transferred their shares from Ping An Securities (Hong Kong) to Yingli Securities, with a transfer market value of HKD 416 million.
On January 19, a shareholder of Xipuni (02583) transferred shares from Ping An Securities (Hong Kong) to Yingli Securities, with a transfer market value of HKD 416 million, accounting for 3.60%.
Shenzhen Hipine Precision Technology And 2 Other Undiscovered Gems In Asia
Specialization and Innovation as the Foundation, Dual-Track Strategy Breakthrough: Xipuni (02583) Achieves Profit Doubling through Technology-Driven Consumer Upgrade
This nearly doubled earnings forecast is strong evidence that Xipuni's long-term commitment to its 'dual-driver' business model and its strategic upgrade of 'branding + intelligence' has entered the harvest phase.
H-share Announcements | Kuaishou-W: Strongly condemns illegal activities by black and gray industries, has reported to the public security authorities and relevant departments.
Grand Pharmaceutical introduces the world's first epinephrine nasal spray for the treatment of severe allergic reactions; China Energy Holdings is set to receive a full acquisition offer at a premium of approximately 9.03%, with trading resuming on December 24.
Cipani Reports Profit Growth: Annual Net Profit Expected to Increase Year-over-Year
Cipani (02583) announced that, based on the preliminary review of the group’s unaudited consolidated management accounts for the 11 months ended November 30, 2025, it recorded a net profit exceeding RMB 90 million. According to the group’s existing information, compared to the net profit of approximately RMB 49 million for the year ended December 31, 2024, the group expects to record a higher net profit for the year ending December 31, 2025.
HIPINE: POSITIVE PROFIT ALERT
Annual Review | Volume and Amount Rise Together! Hong Kong stocks lead the world in new stock fundraising in 2025, with pharmaceutical stocks in high demand; Changfeng Pharmaceutical made nearly HKD 12,000 on the first day.
As of December 18, the Hong Kong stock market has welcomed 102 companies for listing, with the total number of new listings expected to exceed 110 for the year, marking a significant increase from 70 new listings in 2024. The net proceeds raised reached HKD 238.2 billion, representing a substantial year-on-year growth of 246%.
Cipani (02583): Is the 5-fold increase due to arbitrage of the 'Connect' system or value discovery?
The recent rise in Cipani is not primarily driven by changes in fundamentals but is highly correlated with the expectation of its inclusion in the Stock Connect program.
Cipani (02583): Elected Li Yongzhong as Chairman.
Cipani (02583) announced that, following the approval of the shareholders' meeting, Mr. She Ding Shun has been appointed as an independent non-executive director of the fourth board of directors. Mr. Li Yongzhong, Mr. Hu Shaohua, and Mr. Li Yangjin have been re-elected as executive directors of the fourth board of directors, while Mr. Huang Liangdi has been re-elected as a non-executive director of the fourth board of directors. Ms. Guo Xiaohong and Mr. Huang Shanrong have been re-elected as independent non-executive directors of the fourth board of directors. The term of the aforementioned directors is three years, effective from November 28, 2025.
Hong Kong Stock Movement | Xipuoni (02583) Plummets Over 10%: Shares Rose More Than Fivefold in Less Than Two Months After Listing
Chipper (02583) fell more than 10%. The stock was listed on September 30 this year and closed at HKD 194 yesterday, hitting a new high. This represents a cumulative increase of 555% compared to its IPO price of HKD 29.6.
Shenzhen Hipine Precision Technology And 2 Other Asian Hidden Gems With Strong Fundamentals
Cipani (02583) has nominated Ding Shun She for the position of independent non-executive director.
Cipani (02583) announced that Mr. Li Qi and Mr. Lin Yong, who have served as independent non-executive directors for nearly six years, will...